Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
20.01
+0.09 (0.45%)
At close: Dec 8, 2025, 4:00 PM EST
20.30
+0.29 (1.45%)
After-hours: Dec 8, 2025, 5:19 PM EST
Tectonic Therapeutic Employees
Tectonic Therapeutic had 51 employees as of December 31, 2024. The number of employees increased by 7 or 15.91% compared to the previous year.
Employees
51
Change (1Y)
7
Growth (1Y)
15.91%
Revenue / Employee
n/a
Profits / Employee
-$1,319,569
Market Cap
374.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | 7 | 15.91% |
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TECX News
- 21 days ago - Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point - Seeking Alpha
- 5 weeks ago - Tectonic Therapeutic, Inc. (TECX) Discusses Positive Topline Results From Phase Ib Part B Trial of TX45 in PH-HFrEF Patients Transcript - Seeking Alpha
- 5 weeks ago - Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewsWire
- 4 months ago - Tectonic (TECX) Q2 R&D Soars 142% - The Motley Fool
- 5 months ago - Tectonic Therapeutic Joins Russell 3000® Index - GlobeNewsWire
- 7 months ago - Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025 - GlobeNewsWire
- 7 months ago - Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire